Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [973 citations: 101–200 of 931 articles]

Articles published in Prostate Cancer have been cited 973 times. The following is a list of the 931 articles that have cited the articles published in Prostate Cancer.

  • Cheng Fang, Zhong-Qiang Guo, Xiao-Yan Chen, Tong-Zu Liu, Xian-Tao Zeng, and Xing-Huan Wang, “Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer,” Medicine, vol. 96, no. 19, pp. e6791, 2017. View at Publisher · View at Google Scholar
  • Yanmei Li, Ping Wang, Jia Zhao, Haonan Li, Dahai Liu, and Wei Zhu, “HMGB1 attenuates TGF-β-induced epithelial–mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression,” Molecular and Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Jeffrey J. Tosoian, Ridwan Alam, Mark W. Ball, H. Ballentine Carter, and Jonathan I. Epstein, “Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy,” Nature Reviews Urology, 2017. View at Publisher · View at Google Scholar
  • Paul S. Fishman, and Victor Frenkel, “Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease,” Neurotherapeutics, 2017. View at Publisher · View at Google Scholar
  • C Pistore, E Giannoni, T Colangelo, F Rizzo, E Magnani, L Muccillo, G Giurato, M Mancini, S Rizzo, M Riccardi, N Sahnane, V Del Vescovo, K Kishore, M Mandruzzato, F Macchi, M Pelizzola, M A Denti, D Furlan, A Weisz, V Colantuoni, P Chiarugi, and I M Bonapace, “DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • V Di Giacomo, T V Tian, A Mas, M Pecoraro, L Batlle-Morera, L Noya, J Martín-Caballero, J Ruberte, and W M Keyes, “ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • Krystal D. Nolan, Jasmine Kaur, and Jennifer S. Isaacs, “Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity,” Oncotarget, vol. 8, no. 12, pp. 19323–19341, 2017. View at Publisher · View at Google Scholar
  • Fang Quan, Hua Yang, Yuan Shao, Feipeng Zhang, Yanxia Bai, Long Zhou, Bin Li, Tianbo Jin, and Huajing Li, “Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population,” Oncotarget, vol. 8, no. 6, pp. 10255–10263, 2017. View at Publisher · View at Google Scholar
  • Zhi Hong Lu, Sergey Kaliberov, Rebecca E. Sohn, Julie L. Prior, Jennifer K. Sehn, David T. Curiel, Jeffrey M. Arbeit, Lyudmila Kaliberova, Yingqiu Du, Daniel J. Leib, and Anne Chauchereau, “A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector,” Oncotarget, vol. 8, no. 7, pp. 12272–12289, 2017. View at Publisher · View at Google Scholar
  • Kerstin Strömvall, Elin Thysell, Sofia Halin Bergström, and Anders Bergh, “Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis,” Plos One, vol. 12, no. 5, pp. e0176679, 2017. View at Publisher · View at Google Scholar
  • Katarzyna Hojan, Piotr Milecki, Eliza Kwiatkowska-Borowczyk, and Ewa Leporowska, “Inflammation, cardiometabolic markers, and functional changes in men with prostate cancer: A randomized controlled trial of a 12-month exercise program,” Polskie Archiwum Medycyny Wewnetrznej, vol. 127, no. 1, pp. 25–35, 2017. View at Publisher · View at Google Scholar
  • Sergio Faria, Russel Ruo, Fabio Cury, Marie Duclos, and Luis Souhami, “Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiation therapy,” Practical Radiation Oncology, 2017. View at Publisher · View at Google Scholar
  • S A Patel, M-H Chen, M Loffredo, A Renshaw, P W Kantoff, and A V D'Amico, “The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer,” Prostate Cancer and Prostatic Diseases, 2017. View at Publisher · View at Google Scholar
  • M Gacci, G I Russo, C De Nunzio, A Sebastianelli, M Salvi, L Vignozzi, A Tubaro, G Morgia, and S Serni, “Meta-analysis of metabolic syndrome and prostate cancer,” Prostate Cancer and Prostatic Diseases, 2017. View at Publisher · View at Google Scholar
  • Elspeth Raymond, Michael E. O’Callaghan, Jared Campbell, Andrew D. Vincent, Kerri Beckmann, David Roder, Sue Evans, John McNeil, Jeremy Millar, John Zalcberg, Martin Borg, and Kim Moretti, “An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review,” Radiation Oncology, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar
  • J. Cardona Arboniés, B. Rodríguez Alfonso, J. Mucientes Rasilla, C. Martínez Ballesteros, I. Zapata Paz, A. Prieto Soriano, J. Carballido Rodriguez, and M. Mitjavila Casanovas, “La PET/TC con 18 F-Colina en la estadificación y recidiva bioquímica de pacientes con cáncer de próstata: cambios en la clasificación y planificación de radioterapia,” Revista Española de Medicina Nuclear e Imagen Molecular, 2017. View at Publisher · View at Google Scholar
  • J. Cardona Arboniés, B. Rodríguez Alfonso, J. Mucientes Rasilla, C. Martínez Ballesteros, I. Zapata Paz, A. Prieto Soriano, J. Carballido Rodriguez, and M. Mitjavila Casanovas, “18 F-Choline PET/CT scan in staging and biochemical recurrence in prostate cancer patients: Changes in classification and radiotherapy planning,” Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), vol. 36, no. 5, pp. 292–297, 2017. View at Publisher · View at Google Scholar
  • Sorel Kurbegovic, Kasper Drimer Berg, Frederik Birkebæk Thomsen, Lisa Gruschy, Peter Iversen, Klaus Brasso, and Martin Andreas Røder, “The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy,” Scandinavian Journal of Urology, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Mia Møller, Siri Hundtofte Strand, Kamilla Mundbjerg, Gangning Liang, Inderbir Gill, Christa Haldrup, Michael Borre, Søren Høyer, Torben Falck Ørntoft, and Karina Dalsgaard Sørensen, “Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients,” Scientific Reports, vol. 7, pp. 40636, 2017. View at Publisher · View at Google Scholar
  • Florence Lefanc, Nurhayat Tabanca, and Robert Kiss, “Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests,” Seminars in Cancer Biology, 2017. View at Publisher · View at Google Scholar
  • Saheem Ahmad, Hamda Khan, Zeba Siddiqui, Mohd Yasir Khan, Shahnawaz Rehman, Uzma Shahab, Tatyana Godovikova, Vladimir Silnikov, and Moinuddin, “AGEs, RAGEs and s-RAGE; friend or foe for cancer,” Seminars in Cancer Biology, 2017. View at Publisher · View at Google Scholar
  • Rosalyn W. Stewart, Sergio Lizama, Kimberly Peairs, Heather F. Sateia, and Youngjee Choi, “Screening for Prostate Cancer,” Seminars in Oncology, 2017. View at Publisher · View at Google Scholar
  • Frank N. Burks, Jonathan C. Hu, Dinesh Telang, Alice Liu, Scott Hawken, Zack Montgomery, Susan Linsell, James E. Montie, David C. Miller, and Khurshid R. Ghani, “Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative,” The Journal of Urology, 2017. View at Publisher · View at Google Scholar
  • Laura N. Nguyen, Linden Head, Kelsey Witiuk, Nahid Punjani, Ranjeeta Mallick, Sonya Cnossen, Dean A. Fergusson, Ilias Cagiannos, Luke T. Lavallée, Christopher Morash, and Rodney H. Breau, “The Risks and Benefits of Cavernous Neurovascular Bundle Sparing During Radical Prostatectomy: A Systematic Review and Meta-Analysis,” The Journal of Urology, 2017. View at Publisher · View at Google Scholar
  • Se Yun Kwon, Jun Nyung Lee, Yun-Sok Ha, Seock Hwan Choi, Hyun Tae Kim, Tae-Hwan Kim, and Tae Gyun Kwon, “Visible Angle on Magnetic Resonance Imaging Can Be Considered Indicator of Postoperative Outcome in Retropubic Radical Prostatectomy,” The Korean Journal of Urological Oncology, vol. 15, no. 1, pp. 38–43, 2017. View at Publisher · View at Google Scholar
  • Bianca F. Gonçalves, Silvana G.P. de Campos, Rejane M. Góes, Wellerson R. Scarano, Sebastião R. Taboga, and Patricia S.L. Vilamaior, “Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment,” The Prostate, 2017. View at Publisher · View at Google Scholar
  • Margarita Irizarry-Ramírez, Rick A. Kittles, Xuemei Wang, Jeannette Salgado-Montilla, Graciela M. Nogueras-González, Ricardo Sánchez-Ortiz, Lourdes Guerrios, Keila Rivera, Ebony Shah, Ina Prokhorova, Pamela Roberson, Patricia Troncoso, and Curtis A. Pettaway, “Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men,” The Prostate, 2017. View at Publisher · View at Google Scholar
  • Tilman Todenhöfer, Jörg Hennenlotter, Gabriel Keller, Tim Neumann, Arnulf Stenzl, and Jens Bedke, “Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer,” The Prostate, 2017. View at Publisher · View at Google Scholar
  • Thierry Gil, Fouad Aoun, Patrick Cabri, Valérie Perrot, and Roland van Velthoven, “Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study,” Therapeutic Advances in Urology, vol. 9, no. 7, pp. 179–190, 2017. View at Publisher · View at Google Scholar
  • Lei Ge, Yang Yang, Yifeng Sun, Wen Xu, Daru Lu, and Bo Su, “ P73 G4C14-to-A4T14 polymorphism is associated with survival in advanced non-small cell lung cancer patients ,” Thoracic Cancer, 2017. View at Publisher · View at Google Scholar
  • Nitu Kumari, Usha Agrawal, Ashwani Kumar Mishra, Anup Kumar, Pawan Vasudeva, Nayan Kumar Mohanty, and Sunita Saxena, “Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer,” Tumor Biology, vol. 39, no. 4, pp. 101042831769755, 2017. View at Publisher · View at Google Scholar
  • Sundhar Ramalingam, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy, Yuan Wu, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang, “Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2017. View at Publisher · View at Google Scholar
  • E. David Crawford, Andrew V. Schally, Jehonathan H. Pinthus, Norman L. Block, Ferenc G. Rick, Marc B. Garnick, Robert H. Eckel, Thomas E. Keane, Neal D. Shore, David N. Dahdal, Thomas J.R. Beveridge, and Dennis C. Marshall, “The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy,” Urologic Oncology: Seminars and Original Investigations, 2017. View at Publisher · View at Google Scholar
  • Chethan Ramamurthy, Jamie Doyle, Robert G. Uzzo, Alexander Kutikov, Marc C. Smaldone, and Daniel M. Geynisman, “Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space,” Urologic Oncology: Seminars and Original Investigations, 2017. View at Publisher · View at Google Scholar
  • Su-Min Lee, Sidath H. Liyanage, Wahyu Wulaningsih, Konrad Wolfe, Thomas Carr, Choudhry Younis, Mieke Van Hemelrijck, Rick Popert, and Peter Acher, “Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool,” Urologic Oncology: Seminars and Original Investigations, 2017. View at Publisher · View at Google Scholar
  • Richard C. Wu, Yu-Chi Chen, Chung-Hsien Chen, Chun-Hsien Wu, and Victor C. Lin, “Midterm outcomes of four-port extraperitoneal laparoscopic radical prostatectomy for high-risk prostate cancer within Asian population,” Urological Science, 2017. View at Publisher · View at Google Scholar
  • Ted A. Skolarus, Jennifer A. Ragnoni, Carol Garlinghouse, Ann Schafenacker, Debbie Webster, Polly Hager, Daniela Wittmann, and Laurel Northouse, “Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care,” Urology, 2017. View at Publisher · View at Google Scholar
  • Ovidiu Balacescu, Bogdan Petrut, Oana Tudoran, Dragos Feflea, Loredana Balacescu, Andrei Anghel, Ioan O. Sirbu, Edward Seclaman, and Catalin Marian, “Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?,” Wiley Interdisciplinary Reviews: RNA, pp. e1438, 2017. View at Publisher · View at Google Scholar
  • N. Urban, and F. Beyersdorf, “Hypothermie und ihr Einfluss auf das Tumorwachstum,” Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2017. View at Publisher · View at Google Scholar
  • Venkata S. Katabathina, Raghu Vikram, Adeniran Olaoya, Raj Mohan Paspulati, Marlo M. Nicolas, Priya Rao, Atif Zaheer, and Srinivasa R. Prasad, “Neuroendocrine neoplasms of the genitourinary tract in adults: cross-sectional imaging spectrum,” Abdominal Radiology, 2016. View at Publisher · View at Google Scholar
  • H. Xu, P.D. Bai, M.B. Hu, S.H. Mao, W.H. Zhu, J.M. Hu, S.H. Liu, T. Yang, J.Y. Hou, Y. Hu, Q. Ding, and H.W. Jiang, “Infragradación de la biopsia de próstata respecto a la pieza de prostatectomía la población china: nomogramas actualizados,” Actas Urológicas Españolas, 2016. View at Publisher · View at Google Scholar
  • A. Guijarro, L. Reguero, V. Hernández, J.M. de la Morena, E. De la Peña, B. López, B. Fernández, C. Parrilla, E. Pérez-Fernández, I. Alemany, and C. Llorente, “Diagnostic yield and complications of extended lymphadenectomy versus limited lymphadenectomy combined with radical prostatectomy,” Actas Urológicas Españolas (English Edition), 2016. View at Publisher · View at Google Scholar
  • Ayobami Ajayi, Wei-Ting Hwang, Neha Vapiwala, Mark Rosen, Christina H. Chapman, Stefan Both, Meera Shah, Xingmei Wang, Atu Agawu, Peter Gabriel, John Christodouleas, Zelig Tochner, and Curtiland Deville, “Disparities in Staging Prostate Magnetic Resonance Imaging Utilization for Non-Metastatic Prostate Cancer Patients Undergoing Definitive Radiotherapy,” Advances in Radiation Oncology, 2016. View at Publisher · View at Google Scholar
  • Axel S. Merseburger, and Marie C. Hupe, “An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer,” Advances in Therapy, 2016. View at Publisher · View at Google Scholar
  • Aifen Li, Jieyu Xing, Li Li, Changhua Zhou, Bin Dong, Ping He, Qing Li, and Zhong Wang, “A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells,” AMB Express, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yu-Dong Zhang, Chen-Jiang Wu, Mei-Ling Bao, Hai Li, Xu Yan, Xi-Sheng Liu, and Hai-Bin Shi, “New RESOLVE-Based Diffusional Kurtosis Imaging in MRI-Visible Prostate Cancer: Effect of Reduced b Value on Image Quality and Diagnostic Effectiveness,” American Journal of Roentgenology, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Minyong Kang, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Sang Eun Lee, and Seok-Soo Byun, “Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy,” Annals of Surgical Oncology, vol. 23, no. 8, pp. 2699–2706, 2016. View at Publisher · View at Google Scholar
  • Francisco D.C. Guerra Liberal, Adriana Alexandre S. Tavares, and João Manuel R.S. Tavares, “Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153,” Applied Radiation and Isotopes, 2016. View at Publisher · View at Google Scholar
  • Yuejiao Huang, Chun Cheng, Chong Zhang, Yonghui Zhang, Miaomiao Chen, Douglas W. Strand, and Ming Jiang, “Advances in prostate cancer research models: from transgenic mice to tumor xenografting models,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • Jin Xu, and Yun Qiu, “Role of androgen receptor splice variants in prostate cancer metastasis,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • William L. Harryman, James P. Hinton, Cynthia P. Rubenstein, Parminder Singh, Raymond B. Nagle, Sarah J. Parker, Beatrice S. Knudsen, and Anne E. Cress, “The Cohesive Metastasis Phenotype in Human Prostate Cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016. View at Publisher · View at Google Scholar
  • A. Grant Schissler, Ikbel Achour, Haiquan Li, Walter W. Piegorsch, Yves A. Lussier, Qike Li, James L. Chen, Colleen Kenost, and D. Dean Billheimer, “Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells,” Bioinformatics, vol. 32, no. 12, pp. i80–i89, 2016. View at Publisher · View at Google Scholar
  • Lawrence G. Lum, Archana Thakur, Sri Vidya Kondadasula, Zaid Al-Kadhimi, Abhinav Deol, Elyse N. Tomaszewski, Hiroshi Yano, Dana L. Schalk, Lois Ayash, Jeffrey A. Zonder, Joseph P. Uberti, Muneer H. Abidi, and Voravit Ratanatharathorn, “Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Ying Hao, Aidan B. Zerdoum, Alexander J. Stuffer, Ayyappan K Rajasekaran, and Xinqiao Jia, “Biomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide to Promote the 3D Assembly of Tumoroids,” Biomacromolecules, 2016. View at Publisher · View at Google Scholar
  • Ben G. L. Vanneste, Evert J. Van Limbergen, Emile N. van Lin, Joep G. H. van Roermund, and Philippe Lambin, “Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?,” BioMed Research International, vol. 2016, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Domenica Rea, Vitale del Vecchio, Giuseppe Palma, Antonio Barbieri, Michela Falco, Antonio Luciano, Davide De Biase, Sisto Perdonà, Gaetano Facchini, and Claudio Arra, “Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX,” BioMed Research International, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Ruifeng Fan, Haidong Yao, Xia Zhao, Changyu Cao, Tianshu Yang, Yilin Luan, Ziwei Zhang, and Shiwen Xu, “Gene expression of selenoproteins can be regulated by selenoprotein K silencing in chicken myoblasts,” BioMetals, 2016. View at Publisher · View at Google Scholar
  • Tine M. Storebjerg, Søren Høyer, Pia Kirkegaard, Flemming Bro, Torben F. Ørntoft, Michael Borre, and Karina D. Sørensen, “ Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness ,” BJU International, 2016. View at Publisher · View at Google Scholar
  • Kasper D. Berg, Frederik B. Thomsen, Camilla Nerstrøm, Martin A. Røder, Peter Iversen, Birgitte G. Toft, Ben Vainer, and Klaus Brasso, “The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis,” BJU International, vol. 117, no. 6, pp. 883–889, 2016. View at Publisher · View at Google Scholar
  • Jin Tae Kwak, Stephen M. Hewitt, André Alexander Kajdacsy-Balla, Saurabh Sinha, and Rohit Bhargava, “Automated prostate tissue referencing for cancer detection and diagnosis,” BMC Bioinformatics, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Ping Jiang, Christof van der Horst, Bernhard Kimmig, Fabian Zinsser, Bjoern Poppe, Ulf Luetzen, Klaus-Peter Juenemann, Juergen Dunst, and Frank-André Siebert, “Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • V. Atallah, N. Leduc, M. Creoff, P. Sargos, T. Taouil, P. Escarmant, and V. Vinh-Hung, “Curative brachytherapy for prostate cancer in African-Caribbean patients: A retrospective analysis of 370 consecutive cases,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • Payal D. Soni, Alejandro Berlin, Aradhana M. Venkatesan, and Patrick W. McLaughlin, “MRI-guided functional anatomy approach to prostate brachytherapy,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, and Judy E. Garber, “Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care,” Breast Cancer Research and Treatment, 2016. View at Publisher · View at Google Scholar
  • Kristina Stuopelyte, Kristina Daniunaite, Arnas Bakavicius, Juozas R Lazutka, Feliksas Jankevicius, and Sonata Jarmalaite, “The utility of urine-circulating miRNAs for detection of prostate cancer,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Carol E. DeSantis, Rebecca L. Siegel, Ann Goding Sauer, Kimberly D. Miller, Stacey A. Fedewa, Kassandra I. Alcaraz, and Ahmedin Jemal, “Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities,” CA: A Cancer Journal for Clinicians, 2016. View at Publisher · View at Google Scholar
  • Ilinca Georgescu, Robert J. Gooding, R. Christopher Doiron, Andrew Day, Shamini Selvarajah, Chris Davidson, David M. Berman, and Paul C. Park, “Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes,” Cancer & Metabolism, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • William R. Wilcox, Christine Stanislaw, and Yuan Xue, “Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing,” Cancer Biology and Medicine, vol. 13, no. 1, pp. 55–67, 2016. View at Publisher · View at Google Scholar
  • Lei Wang, Hong Ma, Lixia Zhu, Liping Ma, Lanting Cao, Hui Wei, and Jumei Xu, “Screening for the optimal gene and functional gene sets related to breast cancer using differential co-expression and differential expression analysis,” Cancer Biomarkers, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Rebecca L. Siegel, Elizabeth M. Ward, and Ahmedin Jemal, “Global Cancer Incidence and Mortality Rates and Trends-An Update,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 1, pp. 16–27, 2016. View at Publisher · View at Google Scholar
  • Richard M. Hoffman, Angela L. W. Meisner, Wadih Arap, Marc Barry, Satyan K. Shah, Steven B. Zeliadt, and Charles L. Wiggins, “Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 2, pp. 259–263, 2016. View at Publisher · View at Google Scholar
  • Emma H. Allott, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, and Stephen J. Freedland, “Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 3, pp. 547–554, 2016. View at Publisher · View at Google Scholar
  • Ailin Zhang, Jiawei Zhang, Arja Kaipainen, Jared M. Lucas, and Hong Yang, “Long non-coding RNA: A newly deciphered “code” in prostate cancer,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Eileen Brantley, Mariana A. Callero, Damian E. Berardi, Petreena Campbell, Leah Rowland, Dain Zylstra, Louisa Amis, Michael Yee, Marina Simian, Laura Todaro, Andrea Loaiza-Perez, and Ubaldo Soto, “AhR ligand aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Guozhe Xian, Juan Zhao, Chengkun Qin, Zhenhai Zhang, Yanliang Lin, and Zhongxue Su, “Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Alexandru Mihai Nicolae, Niranjan Venugopal, and Ananth Ravi, “Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers,” Cancer Nanotechnology, vol. 7, no. 1, 2016. View at Publisher · View at Google Scholar
  • Claudia Peitzsch, Monica Cojoc, Linda Hein, Ina Kurth, Katrin Maebert, Franziska Trautmann, Barbara Klink, Evelin Schroeck, Manfred P. Wirth, Mechthild Krause, Eduard A. Stakhovsky, GennadyD. Telegeev, Vladimir Novotny, Marieta Toma, Michael Muders, Gustavo B. Baretton, Fiona M. Frame, Norman J. Maitland, Michael Baumann, and Anna Dubrovska, “An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells,” Cancer Research, vol. 76, no. 9, pp. 2637–2651, 2016. View at Publisher · View at Google Scholar
  • Imran Ali, Bettina Julin, Anders Glynn, Johan Högberg, Marika Berglund, Jan-Erik Johansson, Swen-Olof Andersson, Ove Andrén, Edward Giovannucci, Alicja Wolk, Ulla Stenius, and Agneta Åkesson, “Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies,” Carcinogenesis, pp. bgw105, 2016. View at Publisher · View at Google Scholar
  • Antonio Balestrieri, Elena Magnani, and Fiorella Nuzzo, “Unusual Cushing’s Syndrome and Hypercalcitoninaemia due to a Small Cell Prostate Carcinoma,” Case Reports in Endocrinology, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • A J Browne, A Göbel, S Thiele, L C Hofbauer, M Rauner, and T D Rachner, “p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells,” Cell Death and Disease, vol. 7, no. 2, pp. e2119, 2016. View at Publisher · View at Google Scholar
  • Wan Low, and Nahrizul Kadri, “Computational Analysis of Enhanced Circulating Tumour Cell (CTC) Separation in a Microfluidic System with an Integrated Dielectrophoretic-Magnetophorectic (DEP-MAP) Technique,” Chemosensors, vol. 4, no. 3, pp. 14, 2016. View at Publisher · View at Google Scholar
  • Christina Bluemel, and Ken Herrmann, “New technologies in radioguided surgery in complex anatomic areas,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Sergi Vidal-Sicart, and Renato A. Valdés Olmos, “Synergism of SPECT/CT and portable gamma cameras for intraoperative sentinel lymph node biopsy in melanoma, breast cancer, and other malignancies,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • M. R. Grootendorst, M. Cariati, A. Kothari, D. S. Tuch, and A. Purushotham, “Cerenkov luminescence imaging (CLI) for image-guided cancer surgery,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • O. R. Brouwer, H. G. van der Poel, R. F. Bevers, E. J. van Gennep, and S. Horenblas, “Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Renata Zelic, Valentina Fiano, Daniela Zugna, Chiara Grasso, Luisa Delsedime, Lorenzo Daniele, Diego Galliano, Andreas Pettersson, Anna Gillio-Tos, Franco Merletti, and Lorenzo Richiardi, “Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebi,” Clinical Cancer Research, vol. 22, no. 4, pp. 984–992, 2016. View at Publisher · View at Google Scholar
  • Heather K. Neilson, Megan S. Farris, Kerry S. Courneya, and Christine M. Friedenreich, “Physical activity and cancer outcomes: A precision medicine approach,” Clinical Cancer Research, vol. 22, no. 19, pp. 4766–4775, 2016. View at Publisher · View at Google Scholar
  • Adam Kowalewski, Łukasz Szylberg, Anna Skórczewska, and Andrzej Marszałek, “Diagnostic difficulties with atrophy, atypical adenomatous hyperplasia (AAH) and atypical small acinar proliferation (ASAP). A Systematic Review of Current Literature,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • John M. Watkins, Darrion L. Mitchell, J. Kyle Russo, Sarah L. Mott, Chad R. Tracy, Mark C. Smith, and John M. Buatti, “Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • Negar Pouyanfar, Ahmad Monabbati, Alireza Amin Sharifi, and Mehdi Dianatpour, “Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control Study,” Clinical Laboratory, vol. 62, no. 4, pp. 651–657, 2016. View at Publisher · View at Google Scholar
  • G. Giuliani, F. Guerra, D. Coletta, M. La Torre, G. Franco, C. Leonardo, A. Infantino, and F. La Torre, “Repair of transperineal recto-urethral fistula using a fibrin sealant haemostatic patch,” Colorectal Disease, vol. 18, no. 11, pp. O432–O435, 2016. View at Publisher · View at Google Scholar
  • Jean Piechowski, “Trophoblastic-like transdifferentiation: A key to oncogenesis,” Critical Reviews in Oncology/Hematology, 2016. View at Publisher · View at Google Scholar
  • Maria J. Alvarez-Cubero, Fernando Vazquez-Alonso, Ignacio Puche-Sanz, F. Gabriel Ortega, M. Martin-Prieto, Jose L. Garcia-Puche, Manrique Pascual-Geler, Jose A. Lorente, Jose M. Cozar-Olmo, and Maria J. Serrano, “Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications,” Current Drug Targets, vol. 17, no. 6, pp. 693–701, 2016. View at Publisher · View at Google Scholar
  • Maria Raffaella Ambrosio, Luigi Pirtoli, and Maria Teresa del Vecchio, “Emerging Targets for Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach?,” Current Drug Targets, vol. 17, no. 3, pp. 266–275, 2016. View at Publisher · View at Google Scholar
  • Mandi M. Hopkins, and Kathryn E. Meier, “Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk,” Current Nutrition Reports, 2016. View at Publisher · View at Google Scholar
  • Eugene A Zhukovsky, Richard J Morse, and Marcela V Maus, “Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection,” Current Opinion in Immunology, vol. 40, pp. 24–35, 2016. View at Publisher · View at Google Scholar
  • Lisa M. Cordes, James L. Gulley, and Ravi A. Madan, “The evolving role of immunotherapy in prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 232–240, 2016. View at Publisher · View at Google Scholar
  • Manish K. Thakur, and Ulka Vaishampayan, “Multifaceted and personalized therapy of advanced prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 222–231, 2016. View at Publisher · View at Google Scholar
  • Marlon Perera, Todd Manning, Antonio Finelli, and Nathan Lawrentschuk, “Management of men with previous negative prostate biopsy,” Current Opinion in Urology, vol. 26, no. 5, pp. 481–487, 2016. View at Publisher · View at Google Scholar
  • Christina J. Turner, and Claire M. Edwards, “The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease,” Current Osteoporosis Reports, 2016. View at Publisher · View at Google Scholar